SCHEMBL1633158

SCHEMBL1633158

COc1ncc(-c2ccc3cnc(Nc4ccc(S(N)(=O)=O)cc4)nc3c2)cn1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 5/20 0.55
CA2 P00918 5/20 0.55
CA9 Q16790 5/20 0.55
IKBKB O14920 4/20 0.51
CA12 O43570 2/20 0.48
DKK1 O94907 1/20 0.46
GSK3B P49841 1/20 0.46
MAPK10 P53779 2/20 0.44
CA4 P22748 2/20 0.44
JUN P05412 1/20 0.44
MAPK8 P45983 1/20 0.44
CDK2 P24941 4/20 0.44
CCNT1 O60563 3/20 0.44
CDK1 P06493 3/20 0.44
CCNB1 P14635 3/20 0.44
CDK9 P50750 3/20 0.44
CDK7 P50613 1/20 0.44
CCNH P51946 1/20 0.44
CCNB2 O95067 2/20 0.44
CCNE2 O96020 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1633891 0.85 IKBKB (0.54) CA1CA2CA9IKBKBCA12
SCHEMBL1631328 0.85 IKBKB (0.54) CA1CA2CA9IKBKBCA12
SCHEMBL1632143 0.84 MAP4K1 (0.58) CA1CA2CA9IKBKBDKK1
SCHEMBL1634389 0.84 IKBKB (0.49) CA1CA2CA9IKBKBCA12
SCHEMBL1633099 0.83 IKBKB (0.65) CA1CA2CA9IKBKBCA12
SCHEMBL1631337 0.83 CA1 (0.48) CA1CA2CA9IKBKBCA12
SCHEMBL1633611 0.82 SYK (0.54) CA2CA9IKBKBDKK1GSK3B
SCHEMBL1633521 0.82 BRAF (0.54) IKBKBDKK1GSK3BMAPK10MAPK8
SCHEMBL1634526 0.81 CA1 (0.50) CA1CA2CA9IKBKBCA12
SCHEMBL1632940 0.81 PTK2 (0.56) IKBKBDKK1GSK3BMAPK10MAPK8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed